SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bounce Token

Bounce Token is trending as traders discuss its potential for a bull run and analyze its chart patterns for entry points. Community members are speculating on possible partnerships and future price movements, with some expressing frustration over its business model. Recent discussions also highlight the token's volatility and potential for both significant gains and losses.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending amidst community discussions about token burns and potential price movements, with some users expressing bullish sentiment and calling for a push towards higher valuations. However, other users are reporting frustration with the token's recent performance, and highlighting concerns about broader market trends and the potential for a prolonged bear market. The conversation also includes mentions of alternative meme coins and their potential for growth.

Pojak watched as the world played hot potato with CTO shit coins. Now, it's his moment. With Pepe's legendary meme power and Wojak's emotional depth, Pojak brings a new level of influence, wealth, and ethics. Born into meme royalty with luxury and wisdom from Pepe and Wojak, he faced hardship when the original developer rugged the project. The community rose up and took control. Pojak was reborn, stronger and more determined.

Pojak

Pojak ($PJ) is trending, with excitement building around its integration with Phantom Wallet. The community is discussing its potential for significant gains, with many noting "moon vibes" and encouraging others to buy in early. However, some users are urging caution, comparing it to other hyped tokens that ultimately declined.

MLN is the official token of Enzyme. Founded in 2017, Enzyme is the global infrastructure for tokenized finance. Enzyme provides industry leaders with a comprehensive suites of Vault-As-A-Service and Financial Instruments products to manage on-chain assets efficiently, optimize operational processes, and develop innovative financial strategies tailored to their unique goals and challenges.

Melon

Enthusiasm seems to be building around MLN, with community members pointing to its low supply and anticipating a significant price surge reminiscent of other recent pumps. Some are suggesting it's primed for a breakout, while others urge caution, citing potential manipulation and calling for due diligence. The coin's historical price movements and technical indicators are also being closely watched for signals.

GraniteShares ETF Trust - GraniteShares 2x Long INTC Daily ETF

GraniteShares 2x Long INTC Daily ETF

GraniteShares 2x Long INTC Daily ETF ($INTW) is trending as Intel's potential turnaround, driven by progress in its 18A process and customer engagement, gains traction within the investment community. Nvidia's investment in Intel has boosted confidence, with some anticipating Intel outperforming its peers. Bullish technical indicators and anticipation of a positive earnings report are contributing to the upward momentum.

Chubb Ltd. operates as a holding company, which engages in the provision of commercial and personal property and casualty insurance, personal accident and accident and health (A&H), reinsurance, and life insurance. It operates through the following segments: North America Commercial Property and Casualty (P&C) Insurance, North America Personal P&C Insurance, North America Agricultural Insurance, Overseas General Insurance, Global Reinsurance, and Life Insurance. The North America Commercial P&C Insurance segment that includes the business written by Chubb divisions that provide P&C insurance and services to large, middle market and small commercial businesses in the U.S., Canada, and Bermuda. The North America Personal P&C Insurance segment offers affluent and high net worth individuals and families with homeowners, high value automobile and collector cars, valuable articles, personal and excess liability, travel insurance, and recreational marine insurance and services. The North America Agricultural Insurance segment is involved in comprehensive multiple peril crop insurance (MPCI) and crop-hail insurance, and Chubb agribusiness. The Overseas General Insurance segment caters for both commercial and consumer P&C insurance and services in countries and territories outside of North America where the company operates. The Global Reinsurance segment covers reinsurance business. The Life Insurance segment focuses on its international life operations. The company was founded in 1882 and is headquartered in Zurich, Switzerland.

Chubb Limited

Chubb ($CB) is trending amid analyst rating updates and discussions around its potential following a recent earnings report. Community members are weighing JP Morgan and Wells Fargo's updated stances alongside a Wolfe Research upgrade, while also analyzing Chubb's strong premiums and capital base. Some traders are noting unusual options activity, particularly in call options, and are speculating on possible breakout opportunities above the 200-day SMA.

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.

Beam Therapeutics Inc

BEAM is trending due to positive updates on its BEACON Phase 1/2 trial for sickle cell disease, specifically highlighting robust and durable increases in fetal hemoglobin. The community is also discussing analyst upgrades and anticipation of key catalysts in 2025, such as data readouts, while noting the stock's potential for a short squeeze given its high institutional ownership.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending due to updated analyst ratings and discussions around its commercial launch and potential market volatility. The community is weighing perspectives on management's performance, margin improvement plans, and buyout possibilities, particularly in light of its partnership with Johnson & Johnson. High short interest and unusual options activity are also fueling speculation about a potential squeeze.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as the community anticipates the mainnet launch and a potential Coinbase listing. Discussions revolve around its potential to connect all blockchains and banks, rivaling established cryptos like XRP and SOL. Speculation about major partnerships and its unique 'anchor' technology are also fueling the conversation.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as community members express bullish sentiment and highlight the project's strong community. Many reference the "WAGMI" (We're All Gonna Make It) ethos, emphasizing belief and conviction in the project's long-term potential within the crypto space. The community is actively adding to their positions and welcomes new members.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Curious about Washington Trust (WASH) Q3 Performance? Explore Wall Street Estimates for Key Metrics

Evaluate the expected performance of Washington Trust (WASH) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Pathward Financial (CASH) Earnings Expected to Grow: Should You Buy?

Pathward (CASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Washington Trust Bancorp (WASH) Q3 Earnings Expected to Decline

Washington Trust (WASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Washington Trust Announces Date of Third Quarter 2025 Earnings Release, Conference Call and Webcast

Washington Trust Announces Date of Third Quarter 2025 Earnings Release, Conference Call and Webcast Washington Trust Announces Date of Third Quarter 2025 Earnings Release, Conference Call and Webcast...

All You Need to Know About Washington Trust (WASH) Rating Upgrade to Buy

Washington Trust (WASH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Compared to Estimates, Washington Trust (WASH) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Washington Trust (WASH) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Washington Trust Bancorp (WASH) Q2 Earnings and Revenues Top Estimates

Washington Trust (WASH) delivered earnings and revenue surprises of +7.94% and +0.64%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: First Bank (FRBA) Q2 Earnings Expected to Decline

First Bank (FRBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Washington Trust Bancorp (WASH) Reports Next Week: What Awaits?

WBS or WASH: Which Is the Better Value Stock Right Now?

WBS vs. WASH: Which Stock Is the Better Value Option?

Washington Trust Bancorp, Inc. is a bank holding company, which engages in the provision of financial services, including business banking, personal banking and wealth management, and trust services. It operates through the Commercial Banking and Wealth Management Services segment. The Commercial Banking segment includes commercial, residential and consumer lending activities, mortgage banking activities, deposit generation, cash management activities and direct banking activities, which include the operation of ATMs, telephone and internet banking services and customer support and sales. The Wealth Management Services segment consists of investment management, financial planning, personal trust and estate services, including services as trustee, personal representative, custodian and guardian and institutional trust services are also provided, including fiduciary services. The company was founded in 1984 and is headquartered in Westerly, RI.

Washington Trust Bancorp, Inc.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$25.85
Prev Close	$25.45
Open	$25.70
Dividend Yield	7.15%
50-Day Moving Average	$28.87
Beta	1.05
Avg. Volume	121,199.71
PE Ratio	-16.90

52-Week High	$40.59
52-Week Low	$24.95
Market Capitalization	$495.16M
EPS (Annual)	-$1.64
Price to Book	0.94
Revenue Per Employee	$500,110.03
Enterprise Value/EBITDA	N/A

WASH
Washington Trust Bancorp, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest WASH News

WASHWashington Trust Bancorp, Inc.